Panel Urges FDA To Delay Developing QC Standards For Digital Mammography
This article was originally published in The Gray Sheet
Executive Summary
FDA should wait until the American College of Radiology tests quality control procedures for digital mammography before developing regulations on the topic, the agency's mammography advisory panel recommended Sept. 26
You may also be interested in...
Digital Mammography More Accurate Than Film For Younger Women – NEJM
Digital mammography is more accurate than traditional film mammography in women under 50 and women with dense breasts, according to a study slated to appear in the Oct. 27 New England Journal of Medicine
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.